WO2012012500A1 - Systèmes de lecteur optique et tests à flux latéral - Google Patents

Systèmes de lecteur optique et tests à flux latéral Download PDF

Info

Publication number
WO2012012500A1
WO2012012500A1 PCT/US2011/044631 US2011044631W WO2012012500A1 WO 2012012500 A1 WO2012012500 A1 WO 2012012500A1 US 2011044631 W US2011044631 W US 2011044631W WO 2012012500 A1 WO2012012500 A1 WO 2012012500A1
Authority
WO
WIPO (PCT)
Prior art keywords
lateral flow
cassette
test
strip
flow strip
Prior art date
Application number
PCT/US2011/044631
Other languages
English (en)
Inventor
William Fleming
Robert Buck
Ray Miracle
Dan Morrow
Louis Dietz
Scott Myrick
Original Assignee
Nurx Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nurx Pharmaceuticals, Inc. filed Critical Nurx Pharmaceuticals, Inc.
Publication of WO2012012500A1 publication Critical patent/WO2012012500A1/fr
Priority to US14/336,731 priority Critical patent/US20150010992A1/en
Priority to US15/247,729 priority patent/US20160370366A1/en
Priority to US16/258,315 priority patent/US20200001299A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L9/00—Supporting devices; Holding devices
    • B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0825—Test strips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5023—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures with a sample being transported to, and subsequently stored in an absorbent for analysis

Definitions

  • This disclosure relates generally to the detection of analytes in various diagnostic test devices.
  • Analytical tests have been developed for the routine identification or monitoring of physiological and pathological conditions (e.g., pregnancy, cancer, endocrine disorders, infectious diseases) using different biological samples (e.g., urine, serum, plasma, blood, saliva), and for analysis of environmental samples (e.g., natural fluids and industrial plant effluents) for instance for contamination. Many of these tests are based on the highly specific interactions between specific binding pairs. Furthermore, many of these tests involve devices (e.g., solid phase, lateral-flow test strips, flow-through tests) with one or more of the members of a binding pair attached to a mobile or immobile solid phase material such as latex beads, glass fibers, glass beads, cellulose strips or nitrocellulose membranes.
  • devices e.g., solid phase, lateral-flow test strips, flow-through tests
  • test tests suffer from various deficiencies including, for example, test sensitivity, test variability (even among analytical tests of a common lot), cost, and ease of use.
  • the following embodiments relate to systems and methods for determining the presence and/or amount of analytes in a fluid sample.
  • the methods and devices disclosed herein can be used to detect analytes in various types of fluid, including biological specimens (such as blood, serum, plasma, urine, saliva, milk) and environmental samples (such as industrial plant effluent or natural fluids). Results from the methods and devices disclosed herein can be positively read directly from the assay device by visual inspection or using an electronic reader, such as those disclosed herein.
  • an optical reader for performing a diagnostic test on a test sample is provided.
  • the reader comprises a cassette receiving member, an excitation member, and an imaging system.
  • the cassette receiving member is configured to receive at least one cassette comprising a lateral flow strip with a test sample received thereon.
  • the excitation member is positioned to direct excitation energy towards the at least one cassette when the at least one cassette is received by the cassette receiving member.
  • the excitation member comprises a flashlamp that is configured to emit a single flash for each diagnostic test.
  • the imaging system is configured to capture an image of a viewing area. The viewing area comprises at least a portion of the at least one cassette.
  • an optical reader for performing a diagnostic test on a test sample comprises a cassette receiving member, an excitation member, and a CMOS sensor.
  • the cassette receiving member is configured to receive at least one cassette comprising a lateral flow strip with a test sample received thereon.
  • the excitation member is positioned to direct excitation energy towards the at least one cassette when the at least one cassette is received by the cassette receiving member.
  • the CMOS sensor is configured to capture an image of a viewing area, with the viewing area comprising at least a portion of the at least one cassette.
  • a method of performing a diagnostic test comprises positioning a cassette in an optical reader, the cassette comprising at least one lateral flow strip; directing a single flash of excitation energy toward an exposed portion of the at least one lateral flow strip in the cassette; and capturing an image from a viewing area using an imaging system, with the viewing area comprising the exposed portion.
  • a cassette in another embodiment, includes a housing comprising a top member and a bottom member, and a lateral flow strip receiving area located between the top and bottom members.
  • the housing comprises one or more biased members that have a fixed end and a free end, with the free end being configured to contact at least a portion of a lateral flow strip when the lateral flow strip is positioned in the lateral flow strip receiving area.
  • FIG. 1 illustrates an exemplary optical reader system, with portions of the optical reader system shown as transparent.
  • FIG. 2 illustrates a side view of an exemplary optical reader system, with portions of the optical reader system removed for clarity.
  • FIG. 3 is a top perspective view of the optical reader system of FIG. 2.
  • FIG. 4 is a side perspective view of the optical reader system of FIG. 2.
  • FIG. 5 is an exemplary system block diagram for an optical reader system.
  • FIG. 6 is a schematic of a system for exciting a detection zone and directing emitted fluorescent light at an imaging system.
  • FIG. 7 is a schematic of another system for exciting a detection zone and directing emitted fluorescent light at an imaging system.
  • FIG. 8 illustrates a lateral flow immunoassay test strip for use with an optical reader system.
  • FIG. 9 illustrates a cassette member for housing a lateral flow immunoassay test strip such as that shown in FIG. 8.
  • FIG. 11 A illustrates a graph of a TRF signal and a background signal over time.
  • FIG. 1 IB illustrates a graph of a reader signal and flash energy over flash duration.
  • FIG. 12 illustrates a photograph capture of the entire current (Trace A) and light events (Trace B).
  • FIG. 13 illustrates a plurality of lateral flow strips and a detection zone that comprises portions of the different lateral flow strips.
  • FIG. 14 illustrates a cassette configured to hold at least two different lateral flow strips for insertion into a reader system.
  • FIG. 15 illustrates a plurality of lateral flow strips and detection zone that comprises portions of the different lateral flow strips.
  • FIG. 16 illustrates a cassette that comprises a detection zone that includes a portion of a lateral flow strip and a bar code.
  • FIG. 17 illustrates a series of views of a graphical user interface of LCD touchscreen 18 during operation of various testing procedures.
  • FIG. 18 is a flow chart illustrating various steps that can be performed by a reader system.
  • FIGS. 19 and 20 are tables of the results of test and reference line quantization of the TSH test of Example 1.
  • FIG. 21 is a graph of the results of the TSH test of Example 1.
  • FIG. 22 is a schematic view of a cassette that has one or more biased members for securing a lateral flow strip in the cassette.
  • FIG. 23 is a schematic view of the cassette of FIG. 22.
  • FIG. 24 is a view of a bottom part of a cassette, which contains a pair of biased members.
  • FIG. 25 is a bottom view of a cassette that comprises a pair of biased members.
  • FIG. 26 is a top view of a top part of a cassette that houses a lateral flow strip.
  • FIG. 27 is a side view of the top part of FIG. 26.
  • FIG. 28 is a cross-sectional view of the top part of FIG. 26, taken about line A-A.
  • FIG. 29 is a bottom view of the top part of FIG. 26.
  • FIG. 30 is a bottom view of a cassette that comprises a plurality of biased members and a plurality of later flow strips.
  • FIG. 31 is a graph of the results of the FT4 test of Example 2.
  • Analyte An atom, molecule, group of molecules or compound of natural or synthetic origin (e.g. drug, hormone, enzyme, growth factor antigen, antibody, hapten, lectin, apoprotein, cofactor) sought to be detected or measured that is capable of binding specifically to at least one binding partner (e.g. drug, hormone, antigen, antibody, hapten, lectin, apoprotein, cofactor).
  • drug hormone, enzyme, growth factor antigen, antibody, hapten, lectin, apoprotein, cofactor
  • the various embodiments disclosed herein can be practiced with assays for virtually any analyte.
  • the analytes may include, but are not limited to antibodies to infectious agents (such as HIV, HTLV, Helicobacter pylori, hepatitis, measles, mumps, or rubella), cocaine, benzoylecgonine, benzodizazpine, tetrahydrocannabinol, nicotine, ethanol theophylline, phenyloin, acetaminophen, lithium, diazepam, nonryptyline, secobarbital, phenobarbitol, methamphetamine, theophylline, testosterone, estradiol, estriol, 17-hydroxyprogesterone, progesterone, thyroxine, thyroid stimulating hormone, follicle stimulating hormone, luteinizing hormone, transforming growth factor alpha, epidermal growth factor, insulin-like growth factor I and II, growth hormone release inhibiting factor, I
  • Analytes vary in size.
  • small molecule analytes may be, for instance, ⁇ 1.0 nm (such as cotinine or penicillin, each with a molecular weight of less than about 1,000 Daltons).
  • analytes may be larger than this, including for instance immunoglobulin analytes (such as IgG, which is about 8 nm in length and about 160,000 Daltons).
  • Analyte analog A modified analyte that has structural similarity to the unmodified analyte and can bind to at least one analyte binding partner.
  • the analyte analog is an analyte-tracer conjugate, for instance a detectable analyte- tracer conjugate.
  • Label Any molecule or composition bound to an analyte, analyte, analog or binding partner that is detectable by spectroscopic, photochemical, biochemical,
  • labels including enzymes, colloidal gold particles, colored latex particles, have been disclosed (U.S. Pat. Nos. 4,275,149; 4,313,734; 4,373,932; and 4,954,452, each incorporated by reference herein).
  • a compound e.g., an analyte
  • the attachment of a compound can be through covalent bonds, adsorption processes, hydrophobic and/or electrostatic bonds, as in chelates and the like, or combinations of these bonds and interactions and/or may involve a linking group.
  • Lateral flow device Devices that include bibulous or non-bibulous matrices capable of transporting analytes and reagents to a pre-selected site. Many such devices are known, in which the strips are made of nitrocellulose, paper, cellulose, and other bibulous materials. Non-bibulous materials can be used, and rendered bibulous by applying a surfactant to the material.
  • Lateral flow strip A test strip used in lateral flow chromatography, in which a test sample fluid, suspected of containing an analyte, flows (for example by capillary action) through the strip (which is frequently made of materials such as paper or nitrocellulose).
  • the test fluid and any suspended analyte can flow along the strip to a detection zone in which the analyte (if present) interacts with a detection agent to indicate a presence, absence and/or quantity of the analyte.
  • the optical reader system described herein generally comprises an opto-fluorescent instrument with an integrated software analysis capability.
  • the instrument can be a standalone instrument capable of providing a diagnostic result to a user.
  • the reader system can detect a fluorescent signal emitted by a reporter (e.g., a tracer molecule such as an enzyme, fluorophore, or other molecule known to produce a detectable and/or measurable product or signal) to determine the presence and/or amount of analyte in a sample.
  • a reporter e.g., a tracer molecule such as an enzyme, fluorophore, or other molecule known to produce a detectable and/or measurable product or signal
  • a lateral flow chromatography strip can be used in combination with the optical reader system to detect the presence and/or amount of various analytes.
  • FIGS. 1-4 illustrate an optical reader system 10 comprising an imaging system for determining the presence and/or amount of analytes in a fluid sample.
  • Optical reader system 10 comprises a housing 12 that contains an imaging system 26.
  • housing 12 is shown as transparent in FIG. 1 and portions of housing 12 have been removed from FIGS. 2-4.
  • Housing 12 comprises a supporting structure 14 (e.g., a chassis or skeleton) for supporting imaging system 26 and other components (e.g., various optical and electrical components) within housing 12.
  • Housing 12 can also include a receiving member 16 for receiving a sample on a substrate or other sample-carrying structure.
  • Receiving member 16 can comprise, for example, a drawer that is moveable between a first open position for receiving a cassette 15 (FIG. 1), and a second closed position whereby cassette 15 is moved into housing 12 and positioned for analysis by reader system 10.
  • First and second guide members 17 e.g., runners
  • Guide members 17 can have a slot 19 (FIG. 4) or other receiving portions for guiding and receiving the drawer as it moves from the open to the closed position.
  • One or more optical position sensors 21 can be provided to determine whether the drawer and/or cassette are in the proper position for running a test using reader system 10.
  • receiving member 16 can comprise an opening into which a cassette or other sample-carrying structure can be directly received.
  • a display and input screen (e.g., an LCD touchscreen) 18 can be provided on a surface of housing 12.
  • LCD touchscreen 18 can be configured to receive information from a user and to display information to the user about the status of reader system 10 and/or about an analytical test that can be or has been performed by reader system 10.
  • Reader system 10 can be powered by batteries (e.g., batteries 19) and/or it can include a power plug for operating the device on power supplied from an external source, including, for example, AC power.
  • FIG. 17 illustrates a series of views of a graphical user interface of LCD touchscreen 18 during operation of various testing procedures.
  • One or more circuit boards 20, 22 can be provided to control the operation of reader system 10 and display and receive information on LCD touchscreen 18.
  • FIG. 5 illustrates an exemplary system block diagram of reader system 10.
  • a first circuit board 20 can be configured to control the operation of an excitation member 24 (discussed in more detail below) and a second circuit board 22 can be configured to process information or data received from imaging system 26.
  • FIGS. 6 and 7 illustrate schematic representations of the operation of reader system 10.
  • excitation member 24 e.g., a Xenon flashlamp
  • detection zone 32 comprises a portion of a lateral flow strip 33 that comprises one or more reporters (e.g., fluorescent beads 35) that emit fluorescent light 34 when illuminated by excitation member 24.
  • Emitted fluorescent light 34 is directed towards imaging system 26, which can comprise at least one lens 36 and a CMOS sensor 38.
  • Lens 36 can comprise multiple lenses configured to direct and focus light on the sensor 38.
  • lens 36 can comprise a TECHSPEC® Megapixel Finite Conjugate ⁇ -VideoTM Imaging Lens that includes several precision glass elements mounted in a compact aluminum housing. As discussed in more detail below, light from excitation member 24 can be directed through a filter 30 before impacting detection zone 32.
  • imaging system 26 can have a field of view 37 that is capable of detecting the entire detection zone 32.
  • field of view 37 can be sufficiently large to detect multiple detection zones. These multiple detection zones can include portions of multiple lateral flow strips 33 (or other analytical test members) and/or other viewable elements that contain information about the analytical tests being performed by the reader system.
  • the imaging system and related optical elements can comprise multiple filters, lenses, and mirrors in one or more assemblies to focus an image of the detection zone on a sensor of the imaging system.
  • FIGS. 1- 4 and 7 include an optical member 40 (e.g., a mirror) that redirects emitted fluorescent light 34 from the detection zone 32 towards imaging system 26.
  • Imaging System e.g., a mirror
  • the systems and methods disclosed herein generally include imaging systems.
  • the imaging systems disclosed herein can greatly improve the amount of information that can be received, which increases the flexibility in the design of such assay systems. For example, in lateral flow immunoassays, there are typically multiple zones in which the optical signal needs to be measured. While multiple nonimaging detectors can be used to measure the signal from those zones or a single nonimaging detector can be scanned over the device to measure multiple zones, the resulting device is both complex and inflexible in that it can function only with the assay format for which it was designed.
  • the imaging systems described herein can be adapted for use with multiple assay formats by updating the image analysis software which is used to compute the results of the assay. In this manner, the imaging systems of the present disclosure are highly flexible and easily modifiable to perform multiple types of
  • the imaging systems disclosed herein can have spatial resolution, which can be useful in performing quality checks on the assay device. For example, by using spatial resolution, the imaging systems disclosed herein can detect or adapt to imperfections in the operation of the assay device, making the system more robust and reliable.
  • Imaging system 26 can comprise, for example, a CMOS or CCD image sensor, or a 2-dimensional array of photosensitive detectors such as photodiodes, avalanche photodiodes, photomultipliers tubes, or other similar elements.
  • CMOS or CCD image sensor or a 2-dimensional array of photosensitive detectors such as photodiodes, avalanche photodiodes, photomultipliers tubes, or other similar elements.
  • the system microcontroller or microprocessor can analyze the image to automatically locate and measure the assay detection zones, the mechanical tolerances of the system and the assay substrate may be increased, allowing for a lower-cost device.
  • the imaging sensor can be used to detect variation in the assay devices, (such as flow abnormalities in lateral flow assay devices) allowing the microprocessor to detect and/or account for error conditions.
  • the field of view of the imaging sensor can be sufficiently large to image and measure several different areas in a detection zone at once, including, for example, bar code information and/or multiple assays arranged in different locations in the sample cassette (as in Figure 5 below).
  • the imaging of the detection zone can be done by a single image exposure, or using multiple exposures to optimize the imaging and TRF parameters (such as exposure time, flash duration, delay between flash and image exposure, etc.).
  • FIG. 13 illustrates an image of two side-by-side lateral flow immunoassay test strips.
  • the signal (TRF or fluorescent light intensity) can be measured in two zones or "bands" on each test strip to obtain, for example, a ratio of the Test band to the Reference band (T/R ratio).
  • T/R ratio a ratio of the Test band to the Reference band
  • This ratio can be used to normalize the response of the assay to several sources of error or uncertainty that would otherwise make the measurement much less accurate.
  • this T/R ratio could be used together with a lot-specific calibration curve to predict the analyte concentration.
  • the dark reference image can be measured by disabling the illumination source while acquiring the dark reference image.
  • Acquiring the white reference image can be more complex, since it can be difficult to provide a calibration target that will emit uniform TRF signal over a large area, filing the FOV.
  • this problem is resolved by replacing the sample with a calibration target that is a clean, uniform piece of material positioned at or adjacent the location of the sample.
  • the material can scatter illumination energy (e.g. from the flashlamp) toward the imaging optics that form an image on the image sensor. In this manner, the white reference process can correct for both illumination variation and imaging system sensitivity versus position in the FOV.
  • the scattered light that forms the white reference image is at a wavelength that is different from the TRF emission
  • this technique works best if the imaging system sensitivity is the same or largely the same at the illumination wavelength and the TRF emission wavelength.
  • Such a system can be accomplished by, for example, designing the optical system so that chromatic aberrations arc controlled and similar between these two different wavelengths.
  • Scattered illumination light can also be many orders of magnitude brighter than the TRF emission; therefore it can be useful to provide a means to attenuate the white reference signal so that the detector is not saturated, without modifying the illumination pattern across the FOV.
  • this can be accomplished by reducing the intensity and duration of the flashlamp, and by increasing the delay between the flash and the image acquisition, and also by reducing the exposure time of the image sensor, or some combination of all three of these approaches.
  • results of a diagnostic test run by the optical reader systems described herein can be viewed in a number of ways.
  • the results can be displayed on the display screen of the device, printed, and/or delivered to another system for viewing or printing.
  • the information relating to the results of a diagnostic test from the device to a printer or other system can be delivered via a wired or wireless system.
  • a universal serial bus (USB) port or other such output port can be provided to connect the system to an external device to output information from the optical reader system to the external device.
  • USB universal serial bus
  • the establishment of communication between the optical reader system and an external device can allow for information to be exchanged from the external device to the optical reader system.
  • Such information can include, for example, system upgrades and the delivery of additional or modified software for running various diagnostic tests on the optical reader system.
  • the detection zone imaged by the reader systems described herein can be a portion of one or more test strips in a lateral flow device.
  • a test sample fluid that is suspected of containing an analyte can be allowed to flow (for example by capillary action) through the test strip (which is frequently made of materials such as paper or nitrocellulose).
  • the test fluid and any suspended analyte can flow along or through the strip to a detection zone in which the analyte (if present) interacts with a detection agent to indicate a presence, absence and/or quantity of the analyte.
  • the test strip can be configured to detect human thyroid stimulating hormone (hTSH) in human plasma or serum as an aid in the assessment, diagnosis, and treatment of a hypothyroid status and/or condition.
  • Thyroid stimulating hormone (TSH) is released by the pituitary gland and exerts its action upon the thyroid gland, which in turn maintains normal blood levels of the iodothyronines T3 and T4 (thyroxine) in the body.
  • TSH levels are controlled by thyrotropin releasing hormone and through negative feedback of iodothyronines. When thyroid hormone production is impaired, as in primary hypothryroidism, the levels of TSH in the blood rise.
  • TSH levels may be reduced when thyroid hormone production is low, as in secondary or tertiary hypothyroidism. In the case of hyperthyroidism, TSH levels are typically subnormal. Measuring blood levels of TSH provides a way to conveniently screen for thyroid disease and to monitor patients receiving TSH replacement therapy.
  • a test strip 50 can comprise a sample pad 52, a conjugate pad 54, a nitrocellulose membrane 56, and an absorbent pad 58.
  • immunoassay strip can have a test line and a reference/control line provided on the membrane (e.g., by spraying) at specific positions.
  • the test line reagent can comprise an anti-beta TSH antibody and reference/control line can comprise immobilized streptavidin.
  • a reference conjugate of Europium labeled BSA-Biotin can be provided on conjugate pad 54 (e.g., by spraying).
  • a backing 60 can be applied to the membrane 56 and the entire test strip 50 can be inserted into a structural support, such as a cassette.
  • CMEU Latex-TSH antibody conjugate was activated using as follows: To 0.20 ml of ED AC prepared CMEU Latex (Seradyne), is added 800ul of 10 mM Borate buffer.
  • CMEU conjugate is sprayed onto blocked glass at a rate of 4ul/cm and dried to form the conjugate strip.
  • a second conjugate for the reference line is prepared using CMEU Biotin and is manufactured in the same manner.
  • Nitrocellulose striping was accomplished with the TSH conjugate (Medix Anti TSH 5409) in the primary/test zone (ug/ml at 1.0 ul/cm) and streptavidin to the
  • TSH BiosPacific TSH-Ag Jl 1030015
  • TSH BiosPacific TSH-Ag Jl 1030015
  • the calibration test solution's TSH levels were determined using an EI A Kit from Diagnostic Automation, Inc. Cat # 3122-18 and found to be acceptable.
  • a 15mm by 30 cm strip of nitrocellulose was affixed to a 50mm x 300mm adhesive coated vinyl backing.
  • One line of a 1.0ug/ml solution of the anti TSH was applied to (sprayed on) at a rate of lul/cm to the nitrocellulose membrane (primary capture/test) to produce a 1 mm band.
  • One line of a 30ug/ml streptavidin solution was applied to (sprayed on) the nitrocellulose membrane (reference line). The nitrocellulose membrane was dried for 12 hours at 37. degrees C.
  • a sample pad sheet (Whatman Cytosep 1663) was wetted by immersion in a blocking solution then dried overnight. The dried sample pad was then laminated onto the lower portion of the strip. A cellulose pad was laminated to the upper portion of the strip to act as an absorbent reservoir. [0077] The CMEU Latex TSH-antibody/CMEU biotin conjugate strip is then inserted between the membrane and the sample pad with a 2 mm overlap onto the membrane.
  • a 60ul aliquot sample dilution buffer and 60ul aliquot of TSH test solution was added pre-mixed and then added to the sample well of each test strip device. The test strips were allowed to develop for 15 minutes.
  • test strips were then quantitated using the reader system to obtain values for the area of the reference and test lines.
  • the T/R ratio was calculated from the areas, and the calibration curve was established. The results are depicted in Tables 1 and 2 shown in FIGS. 19 and 20, and the graph shown in FIG. 21.
  • FIGS. 9 and 10 illustrate a cassette 70 which can receive test strip 50.
  • Cassette 70 can comprise a sample receiving well 72 of a predetermined volume and a window 74 whereby the portion of the strip that contains the test line and reference/control line can be exposed.
  • a sample of plasma or serum can be placed into sample receiving well 72 (along with any required buffer or other fluid).
  • the sample well can have a volume of about 45-150 ⁇ .
  • Another embodiment can include a lateral flow strip configured to detect hTSH by determining an amount of unbound or free thyroxine (FT4) in a plasma or serum sample.
  • T4 is also bound to thyroxine binding globulin (TBG), albumin, and a host of minor protein contributors, which have varying affinities for the hormone.
  • TBG thyroxine binding globulin
  • the majority of T4 is bound to TBG (over 99.9%) and is in dynamic equilibrium with free and bound forms.
  • the free form is biologically active, along with free T3, and is thought to therefore be a better indicator of activity over the total T4 (where all the T4 has been removed from the bound proteins and then analyzed).
  • the bound form is subject to removal by a number of chemicals, drugs and physiologic conditions that effect release from the bound form.
  • the test can operate with a sample volume in the range of 15-50 ⁇ .
  • a pre-mix step can be provided, whereby an equal volume of a dilution buffer can be added to the sample prior to entering the strip.
  • a dilution buffer of about 30 ⁇ 1 can be added directly to the sample well for premixing with the plasma or serum sample.
  • the sample well can have a barrier (e.g., a pull tab barrier) that prevents the solution from entering the sample pad on the strip until the barrier is removed. Barriers, such as pull tab barriers can assure full sample acquisition, assure sample quantity (no leakage into the system, allowing excess sample - critical when we use sample volume to provide a quantified result), and can control timing (start or total) of the test.
  • a plasma or serum sample of about 30 ⁇ 1 can then be added to the sample well, and the mixture can be gently mixed by pipet action (e.g., stirring) in the well.
  • Sample well preferably is at least about 100 ⁇ , and preferably about 150 ⁇ to hold both the dilution buffer and the plasma or serum sample for premixing.
  • the dilution buffer can be useful in removing non-specific binding to the capture zone in serum and plasma samples, in removing heterophilic antibody interactions and to aid flow of the sample mixture.
  • the barrier can then be removed (e.g., by pulling the pull tab), allowing the sample mixture to flow freely into the sample pad.
  • the sample pad can be made of a blood separation matrix (Cytosep, Ahlstrom). This matrix can remove harmful latex aggregation factors in the serum. After the sample mixture flows through the matrix, it arrives at the conjugate pad.
  • the conjugate pad can contain Carboxy Latex impregnanted with a Europium chelate (CMEU, Seradyne, Inc.) that has a biotinylated anti-T4 antibody coated to the surface of the particle. The T4 in the sample mixture reacts with the CMEU-Ab particle to fill available binding sites.
  • CMEU Europium chelate
  • the sample mixture and particles migrate onto the nitrocellulose membrane and toward the primary capture zone (e.g., the reference line), which is an immobilized 1.0 mm band of BSA-T4.
  • the particles will bind or not bind to the primary capture line depending upon how many available binding sites have not been filled.
  • Those particles leaving the primary capture zone move toward the secondary capture zone (i.e., the test line comprising about 500 ng streptavidin) where the particles containing biotin are captured.
  • the test can be allowed to clear for about 15 minutes. At that time the cassette/strip can be placed in the optical reader system, where a T/R ratio is calculated from the peak areas of the test and reference lines. That T/R value can then correlated with a stored calibration curve to deliver a test result in pg/ml or ng/dL of FT4.
  • a CMEU Latex-T4 antibody-biotin conjugate was prepared using a modification of the procedure used in example 1 , replacing the antibody with anti-T4 monoclonal antibody.
  • the CMEU conjugate is sprayed onto blocked glass at a rate of 1 ⁇ /cm, and dried to form the conjugate strip.
  • Thyroxine (T4, Neogenesis 707801) calibration test solutions were prepared in a human plasma matrix (American Red Cross, 21KR 78229) by spiking with T4 diluted in stripped serum (Biocell 1131-00) to levels of 0, 75, 175 ng/ml T4. Calibration test solutions T4 level was determined using EIA Kit (Diagnostic Automation Incorporated 3146Z) and found to be 13.3, 31.7, 58.0 pg/mL respectively.
  • a 15 mm by 30 cm strip of nitrocellulose (Millipore SHF 1350425) was affixed to adhesive coated vinyl backing (G&L 46166).
  • One line of a 750 ug/ml solution of the BSA-T4 was applied to (sprayed on) at a rate of 1 ⁇ /cm to the nitrocellulose membrane (primary capture/reference) to produce a 1 mm band.
  • One line of a 1000 ug/ml streptavidin solution was applied to (sprayed on) the nitrocellulose membrane (test/read line) to produce a 1 mm band.
  • the nitrocellulose membrane was dried for 65 hours at 37° C
  • a sample pad sheet (Cytosep Ahlstrom 1663) was blocked for 30 minutes in a blocking solution then dried overnight. The dried sample pad was then laminated onto the lower portion of the strip. A cellulose pad (Millipore SA 3J060V04) was laminated to the upper portion of the strip to act as absorbent reservoir. [0095] The CMEU Latex-T4 antibody-biotin conjugate strip is then inserted between the membrane and the sample pad with a 3 mm overlap onto the membrane.
  • a plastic liner strip 4.3 mm x 15 mm (G& L 46166) was cut and placed over the sample well opening of the cassette to act as a sample barrier pull tab.
  • Samples used were thyroxine (T4, Neogenesis 707801) spiked into a human plasma matrix (American Red Cross, 21KR 78229) by spiking with T4 diluted in stripped serum (Biocell 1131-00) to levels of 50 and 125 ng/mL T4.
  • Sample solutions FT4 level were determined using EIA Kit (Diagnostic Automation Incorporated 3146Z) and found to be 21.4 and 44.0 pg/mL respectively.
  • a 60 ul aliquot of the sample and a 60 ul aliquot of FT4 test solution was added to the sample well of each test strip device and mixed with a pipet.
  • the sample well barrier tab was pulled, allowing the solution to be absorbed by the sample pad.
  • the test strips were allowed to develop for 15 minutes.
  • test strips were then quantitated using the reader system to obtain values for the area of the reference and test lines.
  • the T/R ratio was calculated from the areas, and the calibration curve was established. The results are depicted in Tables 1 in FIG. 31.
  • FIG. 18 a flow chart illustrates various steps that can be performed by reader system 10 in connection with the TSH test disclosed above.
  • the optical reader can be adapted to excite and detect various labels that have been captured, or are otherwise present, in lines or areas in a lateral flow assay to provide a quantitative measurement result of the amount of analyte in a sample.
  • the quantitative measurement result can take into consideration a ratio of a measured response in two zones (e.g., a test band to a reference band). In other cases, however, only a single zone can be detected and/or no ratio need be determined in connection with the provision of the quantitative measurement result.
  • Fluorescence detection is commonly used in highly sensitive assay detection or imaging systems, for example biomedical diagnostic or analytical or research devices.
  • Time resolved fluorescence is a powerful detection technique that utilizes fluorescent tags with long emission lifetime, which solves some of the challenges above.
  • brief pulses of light can be used to excite the fluorescent labels or tags, which continue to emit fluorescent signals after the pulse is terminated, typically for times from a few microseconds to hundreds of microseconds.
  • the detection system is triggered to measure the long-lived TRF signal. This is advantageous for the applications described above, because wavelength filtering is sometimes not required at all (or can use lower-performance lower-cost filters) since the detection system measures the signal after the excitation energy has been removed.
  • FIG. 11 A is a chart showing a measured TRF signal relative to a measurement of background noise over time.
  • the excitation member can be a flashlamp that can emit enough excitation energy in a single flash to perform fluorescence or TRF measurements with adequate sensitivity (as opposed to averaging many flashes together to increase the sensitivity).
  • flashlamp technology By using flashlamp technology, a reader system can be provided that is simple and relatively low-cost.
  • Optical filter 30 can pass the desired wavelengths that excite the fluorescent labels and block the longer wavelengths from blackbody radiation emitted by the hot lamp, even after the flashlamp current is terminated. Thus, optical filter 30 can have the effect of greatly reducing unwanted background radiation that would interfere with the measurement. Such a filter is typically much lower cost than the high-performance filters that are required for fluorescence systems with low Stake's shifts, such as the interference filters that are used in conventional fluorescence detection systems to discriminate between the excitation and emission wavelengths.
  • Flashlamps are energized by circuits using high voltage and high currents, to generate high energy flashes with short duration, measured in the range of a few
  • TRF tags and labels such as lanthanide chelates of europium, emit fluorescence over a time range of tens of microseconds to milliseconds.
  • Flashlamp circuits can charge up a capacitor to a high voltage (typically a few hundred volts), and then direct that charge to flow into the flashlamp.
  • the flashlamp 's light emission peaks shortly after the current begins to flow, and then gradually decays (similar to an RC exponential decay curve) over a period as long as hundreds of microseconds or even milliseconds, depending on the capacitance and flashlamp impedance, as shown in FIG. 12.
  • FIG. 12 illustrates a photograph capture of the entire current (Trace A) and light events (Trace B), with the waveform leading edges of FIG. 12 being enhanced for clarity.
  • the light output generally follows the current profile, although peaking is less defined.
  • the flashlamp flash duration shown in FIG. 11 A is 200 microseconds or more, though most of the flashlamp energy is delivered in the first 50 microseconds. By terminating the flash after about 100 microseconds, much more of the TRF signal (shown by the upper curve in FIG. 11 A) can be captured by the detector.
  • FIG. 1 IB illustrates a comparison of TRF signal and flash energy relative to flash duration.
  • a maximum TRF signal can occur with a flash duration of about 100 to 200 microseconds.
  • the flash energy is estimated to be about 2500 mJ, which can desirable result in a longer flashlamp lifetime (e.g., about 10,000 - 20,000 flashes).
  • field of view 37 of the imaging system can be sufficiently large to detect multiple portions of different analytical tests or test members. As shown in FIG. 13, these multiple portions can include, for example, portions of multiple lateral flow strips 47, 49 (or other analytical test members).
  • FIG. 13 illustrates a detection zone 32 of an imaging system that includes portions of two lateral flow strips 47, 49.
  • the portions of two lateral flow strips 47, 49 that are within detection zone 32 include test bands 51, 53 and reference bands 55, 57, respectively. Accordingly, detection zone 32 can be sufficiently large to read the relevant test and reference bands of the two lateral flow strips 47, 49 shown in FIG. 13.
  • lateral flow strips 47, 49 can be included in a single cassette to facilitate loading of the two lateral flow strips into reader system 10.
  • FIG. 14 illustrates lateral flow strips 47, 49 positioned within a cassette 90.
  • detection zone 32 can be sufficiently large to encompass the test and reference bands of lateral flow strips 47, 49.
  • FIG. 14 illustrates four lateral flow strips 61, 63, 65, and 67.
  • each of these lateral flow strips has a portion that falls within detection zone 32 (e.g., a reading window of the imaging system).
  • the portions of the lateral flow strips that fall within the detection zone 32 include test and reference lines as shown in FIG. 14.
  • lateral flow strip 61 can include a sample pad 71, a conjugate pad 73, a membrane 75, and an absorbent pad 77.
  • the relevant portions of lateral flow strips 63, 65, and 67 are unlabeled in FIG. 14. However, it should be understood that those lateral flow strips can be generally similar to lateral flow strip 61.
  • the imaging systems described herein can also be used to image other information present in the field of view of the imaging system.
  • bar-code labels are frequently used in assay systems to provide calibration or lot-specific information that is required to increase the sensitivity or precision of the system. In conventional systems, this information must be read by a specific bar-code reader. In the systems described herein, however, the imaging system can read the bar-code information along with the fluorescent or other signals associated with the assay test itself.
  • many assay devices and systems use calibration techniques to correct for lot-to-lot variations in the disposable cassettes. For example, each batch of manufactured cassettes may have different performance, which requires the reader to correct the
  • FIG. 16 illustrates a cassette 80 that comprises at least one lateral flow strip 82.
  • detection zone 32 of the imaging system is sufficiently larger to capture data from a window 84 in cassette 80 (to read information from lateral flow strip 82) and to capture date from a bar code member 86.
  • Data on the bar code member can include for example a test identifier (e.g., TSH, FT4, TCP, Opiates, etc.), a production lot code, a date of manufacture or update, one or more codes that allow or instruct the reader to adjust the test parameters so that consistent readings are obtained from reader-to-reader and lot-to-lot, and any other information that is necessary or useful for consistent operation of the system.
  • a test identifier e.g., TSH, FT4, TCP, Opiates, etc.
  • a production lot code e.g., FT4, TCP, Opiates, etc.
  • a production lot code e.g., a date of manufacture or update
  • data that define calibration settings that may vary from lot-to-lot can include slope coefficients or spline fit values, camera control variables such as for exposure time, lot codes
  • the bar codes can be printed directly on the test (cassette) housing or onto a label, which can then be affixed to the cassette.
  • the bar codes can be located in a position that can be read by the reader's optical system, such as adjacent a window of a cassette as shown in FIG. 16.
  • the barcode can be illuminated by the flashlamp discussed above to render the barcode easily visible to the imaging system (e.g., a cmos sensor) and decodable by software.
  • a separate illumination member such as a white LED can be used to illuminate the barcode.
  • Lateral flow strips are typically constructed with several layers of materials, intended to channel sampled fluids, such as blood, serum, plasma, urine, oral fluid, vaginal fluids, or collected extracts of the same, diluted or mixed with other fluids, such as buffer, conjugate, or diluents.
  • sampled fluids such as blood, serum, plasma, urine, oral fluid, vaginal fluids, or collected extracts of the same, diluted or mixed with other fluids, such as buffer, conjugate, or diluents.
  • These layers are usually made from fibrous or non-woven materials, used to separate red blood cells from plasma, particulate from urine or oral samples, or to place dried conjugate in the fluid pathway created by this construct.
  • a significant problem with these methods is that the ends of the layers, or pads, can become loosened, and create a blockage to liquid flow.
  • lateral flow strips are encased in a plastic package or cassette that is formed of PVC or another plastic material.
  • the cassette generally includes thin internal walls that press on key locations along the lateral flow strip. These thin walls are usually referred to as pinch points. Pinch points are also critical to control the rate of flow in the lateral flow strip, and, at the sample and, if needed, buffer port, to surround the port to control the flow of fluid(s) into the membranes the make up the device.
  • pinch points can create other problems.
  • the pinch points are too tight, they can cause a blockage of flow, and if too loose, they can cause a flow blockage at the end of the membrane they are intended to assist, or allow fluid to enter the cassette in an uncontrolled flood. Since pinch points are part of the molded cassette, they are subject to manufacturing and material variations that are beyond reasonable means of control.
  • novel cassette devices described herein reduce and/or eliminate the deficiencies described above with conventional pinch points, while allowing optimal control of the pinch points regardless of the manufacturing or material variations.
  • a cassette 100 can comprise one or more biased members 102 configured to provide a force against a lateral flow strip contained in cassette 100.
  • biased members 102 can comprise flow control springs that are positioned on the back of cassette 100.
  • Such biased members 102 can be cantilevered members that have a fixed end 104 (e.g., an end coupled to the cassette 100) and a free end 106.
  • free end 106 of biased member 102 can comprise a protuberance 108.
  • Protuberance 108 can be configured to gently press upon the back of the lateral flow strip within cassette 100, and using the natural flexibility of the cassette material, provides the gentle pressure required for proper liquid flow within the lateral flow strip.
  • Protuberance 108 can be square, round, triangular, or other appropriate shape.
  • FIGS. 24 and 25 illustrate a bottom member 110 of cassette 100, which includes two biased members 102 that are configured to exert an upward force on a lateral flow strip contained in the cassette.
  • the biased members can be configured to exert between about 30 and 400 grams of force to the back of the lateral flow strip and, more preferably, between about 30 and 300 grams of force.
  • FIGS. 26-29 illustrate a top member 112 of cassette 100, which includes a sample well 114 and a viewing window 116.
  • Viewing window 116 is preferably recessed as shown most clearly in FIG. 27.
  • a first pinch point 118 can be provided adjacent sample well 114 by contact with a first biased member 102 and a second pinch point 120 can be provided adjacent window 116 by contact with a second biased member 102.
  • the biased member 102 in contact with the pinch point 118 adjacent sample well 114 can be configured to apply a greater amount of pressure to the lateral flow strip than the other biased member, since it is desirable to prevent flow of the sample mixture in the direction upstream of sample well 114.
  • FIG. 30 illustrates an embodiment with more than two biased members. As discussed above, multiple lateral flow strips can be provided in a single cassette.
  • FIG. 30 illustrates a back of a cassette 130 that comprises four pairs of biased members 132 and 133, 134 and 135, 136 and 137, and 138 and 139.
  • cassettes disclosed herein should be sized to fit the lateral flow strip being housed therein.
  • cassettes of the present disclosure can be between about 40 and 80 mm long and, more preferably, between about 50 and 60 mm; between about 20 and 45 mm wide and, more preferably between about 25 mm and 40 mm wide; and between about 5 and 20 mm in height and, more preferably, between about 5 and 12 mm in height.
  • a cassette is about 56 mm long, 32 mm wide, and has a height of about 8 mm.
  • a window (e.g., window 116 of FIG. 26) is preferably large enough to allow the results of a lateral flow assay to be read by an optical reader as described herein.
  • the window is between about 5 and 20 mm long and between about 2 and 10 mm wide;
  • the cassette window can be about 12 mm long and 4 mm wide.
  • the viewing area of the optical reader can comprise more than just the window area of the cassette.
  • the window can also have a depth, such as that shown in FIGS. 7, 27, and 28. As shown in FIG. 7, the window depth can facilitate the delivery and/or receipt of light to and/or from the strip.
  • an excitation member 24 e.g., a flashlamp
  • an off-set orientation e.g., a non-normal orientation
  • light from the excitation member 24 can reach a greater portion of the strip since the cassette has an angled (or recessed) area.
  • the depth of the window can be between about 1 mm and 3 mm (e.g., about 2 mm).
  • the biased members described herein are preferably positioned on the bottom portion of the cassette as shown in the figures; however, it is possible to place them on a top portion.
  • one or more microfluidic channels can be provided in the cassette to restrict or direct flow of the sample mixture in a desired direction.
  • one or more microfluidic channels can be provided at or adjacent pinch points 118, 120 to reduce pressure on the lateral flow strip and cause fluid flow to move through the test strip and the microfluidic channels in the desired direction.
  • a wall member 124 comprises microfluidic channels that reduce pressure and encourage flow of the sample mixture through the channels of wall member 124.

Abstract

L'invention concerne des cassettes pour bandes pour flux latéral comprenant un boîtier avec un élément supérieur et un élément inférieur ; et une zone de réception de bande pour flux latéral située entre les éléments supérieur et inférieur. Le boîtier comprend un ou plusieurs éléments orientés (102) qui comportent une extrémité fixe (104) et une extrémité libre (106), l'extrémité libre (106) étant conçue pour entrer en contact avec au moins une partie d'une bande pour flux latéral lorsque la bande pour flux latéral est placée dans la zone de réception de bande pour flux latéral.
PCT/US2011/044631 2010-07-20 2011-07-20 Systèmes de lecteur optique et tests à flux latéral WO2012012500A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US14/336,731 US20150010992A1 (en) 2010-07-20 2014-07-21 Optical reader systems and lateral flow assays
US15/247,729 US20160370366A1 (en) 2010-07-20 2016-08-25 Optical reader systems and lateral flow assays
US16/258,315 US20200001299A1 (en) 2010-07-20 2019-01-25 Optical reader systems and lateral flow assays

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36613010P 2010-07-20 2010-07-20
US61/366,130 2010-07-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US14/258,995 Continuation-In-Part US20140227681A1 (en) 2010-07-20 2014-04-22 Optical reader system

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13978116 A-371-Of-International 2011-07-20
US14/336,731 Continuation US20150010992A1 (en) 2010-07-20 2014-07-21 Optical reader systems and lateral flow assays

Publications (1)

Publication Number Publication Date
WO2012012500A1 true WO2012012500A1 (fr) 2012-01-26

Family

ID=44504197

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/044631 WO2012012500A1 (fr) 2010-07-20 2011-07-20 Systèmes de lecteur optique et tests à flux latéral

Country Status (1)

Country Link
WO (1) WO2012012500A1 (fr)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140312247A1 (en) * 2013-04-18 2014-10-23 Bio-Rad Laboratories, Inc. Fluorescence imager on a mobile device
WO2015016960A1 (fr) * 2013-07-30 2015-02-05 Express Diagnostics Int'l., Inc. Lecteur d'analyse universel
US20150098873A1 (en) * 2013-10-08 2015-04-09 Hui-Chi Ku Test cassette
WO2015158818A1 (fr) * 2014-04-16 2015-10-22 Amodia Bioservice Gmbh Module microfluidique et cartouche de diagnostic immunologique et moléculaire dans un analyseur automatique
US20160033501A1 (en) * 2013-03-13 2016-02-04 Denka Seiken Co., Ltd. Test kit
EP3009845A1 (fr) 2014-10-17 2016-04-20 Laboratorios Alpha San Ignacio Pharma S.L. Analyseur portatif pour effectuer automatiquement des dosages immunologiques et pour l'analyse et l'interprétation des résultats correspondants
WO2017134265A1 (fr) 2016-02-05 2017-08-10 Institut Pasteur Utilisation d'inhibiteurs d'adam12 comme adjuvants dans les traitement antitumoraux
US9897601B2 (en) 2013-03-13 2018-02-20 Denka Seiken Co., Ltd Test kit
US10376880B2 (en) 2013-07-30 2019-08-13 Carehealth America Corporation Lateral flow devices and methods of manufacture and use

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4313734A (en) 1978-07-13 1982-02-02 Akzona Incorporated Metal sol particle immunoassay
US4373932A (en) 1980-01-11 1983-02-15 Akzona Incorporated Application of water-dispersible hydrophobic dyes or pigments as labels in immunoassays
US4954452A (en) 1987-07-09 1990-09-04 Abbott Laboratories Non-metal colloidal particle immunoassay
EP0806666A2 (fr) * 1996-05-09 1997-11-12 Syntron Bioresearch, Inc. Procédé et appareil pour essais de sang complet en un seul temps
US6372516B1 (en) * 2000-09-07 2002-04-16 Sun Biomedical Laboratories, Inc. Lateral flow test device
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
US20040018114A1 (en) * 2002-07-26 2004-01-29 Chia-Lin Wang Test strip holder for a reagent test strip
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US20040241752A1 (en) * 1998-02-03 2004-12-02 Anderson Emory V. Point of care diagnostic systems
US20060008847A1 (en) * 2004-05-04 2006-01-12 Ramel Urs A Mechanical cartridge with test strip fluid control features for use in a fluid analyte meter
EP1813949A1 (fr) * 2006-01-03 2007-08-01 Dräger Safety AG & Co KGaA Cassette de test pour analyses de liquides
WO2010017299A2 (fr) * 2008-08-05 2010-02-11 Inverness Medical Switzerland Gmbh Plate-forme universelle de tests pour diagnostics médicaux et appareil de lecture de plates-formes de tests

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313734A (en) 1978-07-13 1982-02-02 Akzona Incorporated Metal sol particle immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4373932A (en) 1980-01-11 1983-02-15 Akzona Incorporated Application of water-dispersible hydrophobic dyes or pigments as labels in immunoassays
US4954452A (en) 1987-07-09 1990-09-04 Abbott Laboratories Non-metal colloidal particle immunoassay
EP0806666A2 (fr) * 1996-05-09 1997-11-12 Syntron Bioresearch, Inc. Procédé et appareil pour essais de sang complet en un seul temps
US20040241752A1 (en) * 1998-02-03 2004-12-02 Anderson Emory V. Point of care diagnostic systems
US6699722B2 (en) 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes
US6372516B1 (en) * 2000-09-07 2002-04-16 Sun Biomedical Laboratories, Inc. Lateral flow test device
US20040018576A1 (en) * 2002-07-24 2004-01-29 Dematteo Todd M. Bence Jones protein testing cassette
US20040018114A1 (en) * 2002-07-26 2004-01-29 Chia-Lin Wang Test strip holder for a reagent test strip
US20060008847A1 (en) * 2004-05-04 2006-01-12 Ramel Urs A Mechanical cartridge with test strip fluid control features for use in a fluid analyte meter
EP1813949A1 (fr) * 2006-01-03 2007-08-01 Dräger Safety AG & Co KGaA Cassette de test pour analyses de liquides
WO2010017299A2 (fr) * 2008-08-05 2010-02-11 Inverness Medical Switzerland Gmbh Plate-forme universelle de tests pour diagnostics médicaux et appareil de lecture de plates-formes de tests

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160033501A1 (en) * 2013-03-13 2016-02-04 Denka Seiken Co., Ltd. Test kit
US9897601B2 (en) 2013-03-13 2018-02-20 Denka Seiken Co., Ltd Test kit
US10295533B2 (en) * 2013-03-13 2019-05-21 Denka Seiken Co., Ltd. Test kit
US20140312247A1 (en) * 2013-04-18 2014-10-23 Bio-Rad Laboratories, Inc. Fluorescence imager on a mobile device
WO2015016960A1 (fr) * 2013-07-30 2015-02-05 Express Diagnostics Int'l., Inc. Lecteur d'analyse universel
US10376880B2 (en) 2013-07-30 2019-08-13 Carehealth America Corporation Lateral flow devices and methods of manufacture and use
US20150098873A1 (en) * 2013-10-08 2015-04-09 Hui-Chi Ku Test cassette
WO2015158818A1 (fr) * 2014-04-16 2015-10-22 Amodia Bioservice Gmbh Module microfluidique et cartouche de diagnostic immunologique et moléculaire dans un analyseur automatique
EP3009845A1 (fr) 2014-10-17 2016-04-20 Laboratorios Alpha San Ignacio Pharma S.L. Analyseur portatif pour effectuer automatiquement des dosages immunologiques et pour l'analyse et l'interprétation des résultats correspondants
WO2017134265A1 (fr) 2016-02-05 2017-08-10 Institut Pasteur Utilisation d'inhibiteurs d'adam12 comme adjuvants dans les traitement antitumoraux

Similar Documents

Publication Publication Date Title
US20140227681A1 (en) Optical reader system
US20200001299A1 (en) Optical reader systems and lateral flow assays
US20210293793A1 (en) Interactive test device and apparatus with timing mechanism
US20150010992A1 (en) Optical reader systems and lateral flow assays
US10852299B2 (en) Optical assay device with pneumatic sample actuation
WO2012012500A1 (fr) Systèmes de lecteur optique et tests à flux latéral
US9488585B2 (en) Reader devices for optical and electrochemical test devices
US9140693B2 (en) Integrated test device for optical detection of microarrays
EP2795328B1 (fr) Dispositif d'essai intégré pour dosages optiques et électrochimiques
EP2385369B1 (fr) Lecteur d'analyse pouvant servir à scanner une bandelette réactive
AU2010236424B2 (en) Diagnostic devices and related methods
EP3077798B1 (fr) Procédé de réduction de la variabilité d'un analyseur au moyen d'une cible de normalisation
US20100176279A1 (en) Methods and materials for detecting light released from a labeling material

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11746693

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11746693

Country of ref document: EP

Kind code of ref document: A1